Patent · US Active

Diagnostic and prognostic tests

US8551700B2 · kind B2 · utility

0Cited by
4References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 12, 2010
Grant dateOct 8, 2013
Priority date
Expiry dateJul 12, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.